Deutsche Bank
OYST

Deutsche Bank’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Deutsche Bank’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6,202
Closed -$72K – 4425
2022
Q1 		$72K Sell
6,202
-720
-10% -$8.57K ﹤0.01% 3704
2021
Q4 		$126K Buy
6,922
+360
+5% +$4.57K ﹤0.01% 3603
2021
Q3 		$78K Sell
6,562
-200
-3% -$2.91K ﹤0.01% 3990
2021
Q2 		$116K Buy
6,762
+2,780
+70% +$52.8K ﹤0.01% 4077
2021
Q1 		$73K Sell
3,982
-504
-11% -$10.6K ﹤0.01% 4128
2020
Q4 		$84K Buy
4,486
+1,283
+40% +$27.7K ﹤0.01% 3941
2020
Q3 		$68K Buy
3,203
+724
+29% +$16.9K ﹤0.01% 3736
2020
Q2 		$72K Buy
2,479
+542
+28% +$16.3K ﹤0.01% 3627
2020
Q1 		$68K Buy
1,937
+52
+3% +$1.68K ﹤0.01% 3411
2019
Q4 		$46K Buy
+1,885
New +$33.1K ﹤0.01% 4011

Other funds holding OYST

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Deutsche Bank's OYST Position: Q2 2022 in Review

Deutsche Bank sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q2 2022, closing a stake of 6,202 shares — an estimated $72K sold.

Deutsche Bank first reported a position in OYST in Q4 2019 and held it in 10 quarters. The position peaked at $126K in Q4 2021. 61 funds tracked by Wall St. Rank hold OYST as of Q2 2022.

  • Deutsche Bank reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Deutsche Bank sold 6,202 Oyster Point Pharma, Inc. Common Stock shares in Q2 2022, an estimated $72K.
  • Deutsche Bank first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2019 and held it in 10 quarters.
  • Deutsche Bank's Oyster Point Pharma, Inc. Common Stock position peaked at $126K in Q4 2021.
  • 61 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q2 2022.

Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.